By amorse
Most people have experienced episodic GI trouble—enough to know how disruptive it can be. But for the one in five U.S. adults with conditions like irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), the disruption is chronic and can affect every dimension of daily life. Yet patients frequently lack access to the coordinated, specialized … Continued
By amorse
This report explores evidence standards, performance monitoring, and policies needed to build confidence in autonomous clinical AI among stakeholders.
By amorse
AI is already playing a role in mental health care. The question is not whether we are comfortable with it, but how we shape it responsibly.
By amorse
Performance-based contracts represent an important step forward to tie payments to measurable outcomes.
By amorse
The $50 billion invested has taught us valuable lessons. If we follow the evidence, we have no excuse not to get this right.
By amorse
This report is designed to be an employer purchasing guide for GLP-1 coverage and virtual solutions.
By amorse
Purchasers remain committed to digital health but demand evidence of measurable outcomes. This survey reveals their priorities and future plans.
By amorse
The 2025 PHTI Summit explored digital health’s evolution: employers demanding measurable outcomes, performance-based contracts rising, AI adoption accelerating, and industry maturing beyond engagement metrics.
By amorse
The Peterson Center on Healthcare’s report highlights opportunities to better align payment to value.
By amorse
PHTI research indicates that ambient scribes are potentially effective at reducing clinician documentation time and cognitive load.